Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haesook T Kim

Showing results (111-120 of 180) with videos related to

Pageof 18
Sort By:
Blood|December 17, 2015
Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHDAna C Alho, Haesook T Kim, Marie J Chammas, et al.
Blood Advances|September 28, 2021
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitutionKatie Maurer, Haesook T Kim, Thomas M Kuczmarski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2018
Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell TransplantationMerve Postalcioglu, Haesook T Kim, Faruk Obut, et al.
Blood|December 21, 2013
Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusionPavan Bachireddy, Ursula Hainz, Michael Rooney, et al.
Haematologica|May 27, 2014
Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantationKazuyuki Murase, Haesook T Kim, O R Gregory Bascug, et al.
Blood Advances|April 3, 2019
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host diseaseJennifer S Whangbo, Haesook T Kim, Sarah Nikiforow, et al.
Blood Advances|April 27, 2022
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host diseaseJennifer S Whangbo, Sarah Nikiforow, Haesook T Kim, et al.
Haematologica|April 29, 2022
Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantationBenedetta Rambaldi, Haesook T Kim, Yohei Arihara, et al.
The New England Journal of Medicine|December 2, 2011
Interleukin-2 and regulatory T cells in graft-versus-host diseaseJohn Koreth, Ken-ichi Matsuoka, Haesook T Kim, et al.
Blood Advances|April 11, 2019
Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemiaBenjamin L Lampson, Haesook T Kim, Matthew S Davids, et al.
Pageof 18

Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
Blood|December 17, 2015
Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHDAna C Alho, Haesook T Kim, Marie J Chammas, et al.
Blood Advances|September 28, 2021
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitutionKatie Maurer, Haesook T Kim, Thomas M Kuczmarski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2018
Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell TransplantationMerve Postalcioglu, Haesook T Kim, Faruk Obut, et al.
Blood|December 21, 2013
Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusionPavan Bachireddy, Ursula Hainz, Michael Rooney, et al.
Haematologica|May 27, 2014
Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantationKazuyuki Murase, Haesook T Kim, O R Gregory Bascug, et al.
Blood Advances|April 3, 2019
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host diseaseJennifer S Whangbo, Haesook T Kim, Sarah Nikiforow, et al.
Blood Advances|April 27, 2022
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host diseaseJennifer S Whangbo, Sarah Nikiforow, Haesook T Kim, et al.
Haematologica|April 29, 2022
Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantationBenedetta Rambaldi, Haesook T Kim, Yohei Arihara, et al.
The New England Journal of Medicine|December 2, 2011
Interleukin-2 and regulatory T cells in graft-versus-host diseaseJohn Koreth, Ken-ichi Matsuoka, Haesook T Kim, et al.
Blood Advances|April 11, 2019
Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemiaBenjamin L Lampson, Haesook T Kim, Matthew S Davids, et al.
Pageof 18